Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: A proof of concept

Human Reproduction

Volumn 22, Issue 5, 2007, Pages 1260-1263

  Fatemi, H M ^a,b   Bourgain, C ^b   Donoso, P ^a   Blockeel, C ^a   Papanikolaou, E G ^a   Popovic Todorovic, B ^a   Devroey, P ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Dydrogesterone; Luteal phase; Micronized progesterone; Oral progesterone; Premature ovarian failure

Indexed keywords

DYDROGESTERONE; ESTRADIOL; ESTRADIOL VALERATE; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; ENDOMETRIUM; FEMALE; FOLLITROPIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; MULTIPLE CYCLE TREATMENT; PILOT STUDY; PREMATURE OVARIAN FAILURE; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; BLOOD; CYTOLOGY; DRUG EFFECT; INTRAVAGINAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PHYSIOLOGY;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADULT; DYDROGESTERONE; ENDOMETRIUM; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEAL PHASE; LUTEINIZING HORMONE; OVARIAN FAILURE, PREMATURE; PILOT PROJECTS; PROGESTERONE;

EID: 34447097294     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del520     Document Type: Article

References (18)

1. Albano C, Smitz J, Tournaye H, Riethmuller-Winzen H, Van Steirteghem A and Devroey P (1999) Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/ intracytoplasmic sperm injection cycles. Hum Reprod 14,1426-1430.
2. Balasch J, Vanrell, JA, Marquez M, Burzaco I and Gonzalez-Merlo J (1982) Dehydrogesterone versus vaginal progesterone in the treatment of the endometrial Luteal phase deficiency. Fertil Steril 37,751-754.
3. Beck-Peccoz P and Persani L (2006) Premature ovarian failure. Orphanet J Rare Dis 6,1-9.
4. Bourgain C, Devroey P, Van Waesberghe L, Smitz J and Van Steirteghem AC (1990) Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Hum Reprod 5,537-543.
5. Chakravarty BN, Shirazee HH, Dam P, Goswami SK, Chatterjee R and Glosh S (2005) Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: Results of a randomised study. J Steroid Biochem Mol Biol 97,416-420.
6. Coutifaris C, Myers ER, Guzick DS, Diamond MP Carson SA, Legro RS, Mc Govern PG, Schlaff WD, Carr BR, Steinkampf MP, et al. (2004) Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril 82,1264-1272.
7. Dallenbach-Hellweg G (1984) The endometrium of infertility. A review. Pathol Res Pract 178,527-537.
8. De Ziegler D and Fanchin R (2000) Progesterone and progestins: applications in gynecology. Steroids 65,671-679.
9. Devroey P, Palermo G, Bourgain C, Van Waesberghe Smitz J and Van Steirteghem AC (1989) Progesterone administration in patients with absent ovaries. Int J Fertil 34,188-193.
10. King RJB and Whitehead MI (1986) Assessment of the potency of orally administered progestins in women. Fertil Steril 46,1062-1066.
11. Li TC, Warren MA and Cookie ID (1994) The artificial cycle as an effective treatment of persistently retarded endometrium in the luteal phase. Hum Reprod 9,409-412.
12. Messinis IE (2006) Ovarian feedback, mechanism of action and possible clinical implications. Hum Reprod Update, 12,557-571.
13. Nosarka S, Kruger T, Siebert I and Grove D (2005) Luteal phase support in in-vitro fertilization: A meta-analysis of randomized trials. Gynecol Obstet Invest 60,67-74.
14. Noyes RW, Hertig AJ and Rock J (1950) Dating the endometrial biopsy. Fertil Steril 1,3-25.
15. Pellicer A, Matallin P, Miro F, Rivera J and Bonilla-Musoles FM (1989) Progesterone versus dehydrogesterone as replacement therapy in women with premature ovarian failure. Hum Reprod 4,777-781.
16. Penzias AS (2002) Luteal phase support. Fertil Steril 77,318-323.
17. Soules MR, Steiner RA, Clifton DK, Cohen NL, Aksel S and Bremmer WJ (1984) Progesterone modulation of pulsatile luteinizing hormone secretion in normal women. J Clin Endocrinol Metab 58,378-383.
18. Whitehead MI, Townsend PT, Gill DK, Collins WP and Campbell S (1980) Absorption and metabolism of oral progesterone. Br Med J 22,825-827.